1. A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. (4th November 2015) Authors: Papadopoulos, Kyriakos P; Tsai, Frank; Hamid, Omid; Xiao, Feng; Steele, Keith E; Rebelatto, Marlon C; Robbins, Paul B; Karakunnel, Joyson J; Lai, Dominic W; Mahipal, Amit Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study. (4th November 2015) Authors: Naing, Aung; Infante, Jeffrey R; Papadopoulos, Kyriakos P; Autio, Karen A; Wong, Deborah J; Falchook, Gerald S; Patel, Manish R; Pant, Shubham; Whiteside, Melinda; Bendell, Johanna; Bauer, Todd M; Janku, Filip; Javle, Milind; Colen, Rivka; Tannir, Nizar; Oft, Martin Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Issue 11 (November 2019) Authors: Naing, Aung; Wong, Deborah J; Infante, Jeffrey R; Korn, W Michael; Aljumaily, Raid; Papadopoulos, Kyriakos P; Autio, Karen A; Pant, Shubham; Bauer, Todd M; Drakaki, Alexandra; Daver, Naval G; Hung, Annie; Ratti, Navneet; McCauley, Scott; Van Vlasselaer, Peter; Verma, Rakesh; Ferry, David; Oft, Ma... Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: 1544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Issue 1 (21st December 2022) Authors: Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Ja... Journal: Neuro-oncology advances Issue: Volume 5:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2, in patients with advanced solid tumors. Issue 2 (24th August 2020) Authors: Naing, Aung; Eder, Joseph P; Piha-Paul, Sarina A; Gimmi, Claude; Hussey, Elizabeth; Zhang, Sen; Hildebrand, Vera; Hosagrahara, Vinayak; Habermehl, Christina; Moisan, Jacques; Papadopoulos, Kyriakos P Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗